From: Treatment patterns for ductal carcinoma in situ from 2000–2010 across six integrated health plans
Characteristic | Number | Percent |
---|---|---|
Race/Ethnicity | ||
White | 5978 | 63.3 |
African American | 1086 | 11.5 |
Asian | 1455 | 15.4 |
Hispanic | 918 | 9.7 |
Year of Diagnosis | ||
2000-2002 | 2043 | 21.6 |
2003-2004 | 1650 | 17.5 |
2005-2006 | 1837 | 19.5 |
2007-2008 | 2001 | 21.2 |
2009-2010 | 1906 | 20.2 |
Age at Diagnosis | ||
<50 years | 1978 | 21.0 |
50 – 59 years | 2917 | 30.9 |
60 – 69 years | 2651 | 28.1 |
> = 70 years | 1891 | 20.0 |
Comorbidity Index | ||
0 | 6898 | 73.1 |
1 | 1654 | 17.5 |
2+ | 885 | 9.4 |
Nuclear Grade | ||
Low/Intermediate | 4702 | 49.8 |
High | 3727 | 39.5 |
Unknown | 1008 | 10.7 |
First course surgical therapy | ||
Breast conserving surgery (BCS) | 2689 | 28.5 |
BCS + radiation | 3978 | 42.2 |
Bilateral mastectomy | 448 | 4.7 |
Unilateral mastectomy | 2322 | 24.6 |
Hormone Therapy* | ||
Yes | 2625 | 27.8 |
No | 6812 | 72.2 |